Streetbeat News

Regulatory

BTCUSD

2024 Democratic Party presidential candidate Robert F. Kennedy Jr. expressed his support for Bitcoin at the Bitcoin Conference 2023, stating that he would promote its growth in the U.S. if elected. He criticized the Federal Reserve's digital currency, FedNow CBDC, and said he would ensure citizens have their own wallets and passwords without government interference.

Portfolio Pulse from Murtuza Merchant

May 19, 2023 | 6:35 pm

BYD

TSLA

China has reportedly rejected Tesla's application to build the 'Model 2' in Shanghai due to concerns it would challenge local leader BYD in the low-priced $25K category, according to a tweet by Gordon Johnson.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 6:28 pm

CRMD

CorMedix has resubmitted its New Drug Application for DefenCath to the FDA, with potential approval in 2023. JMP Securities has increased the price target for CorMedix from $16 to $19, maintaining a Market Outperform rating. The company has a cash position of $59 million, sufficient to fund operations until 1H 2024.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 6:09 pm

KRYS

Krystal Biotech has received FDA approval for its first-ever redosable gene therapy, VYJUVEK, for the treatment of Dystrophic Epidermolysis Bullosa (DEB). The topical gel addresses the genetic cause of DEB by restoring functional copies of the COL7A1 gene. The Phase 3 trial met its primary and secondary endpoints, and the company will host an investor conference call on May 19, 2023.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 6:04 pm

ABBV

GMAB

The FDA has approved Epkinly, a T-cell engaging bispecific antibody for adult patients with relapsed or refractory diffuse large B-cell lymphoma, co-developed and co-commercialized by Genmab A/S (GMAB) and AbbVie Inc (ABBV). The drug demonstrated a 61% overall response rate and 38% complete remission in a Phase 2 study.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 5:59 pm

ABT

STXS

Stereotaxis Inc (STXS) and Abbott Laboratories (ABT) have announced a global collaboration to integrate Abbott's EnSite X EP System with Stereotaxis' Robotic Magnetic Navigation systems. The integrated technologies are cleared for use in Europe, with additional regulatory clearances expected in the coming months. The FDA also approved Abbott's TactiFlex Ablation Catheter, Sensor Enabled.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 5:23 pm

SPY

House Speaker McCarthy stated that the lack of movement by the White House is the reason for the pause in negotiations.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 4:50 pm

GOVT

SPY

Fed Chair Jerome Powell suggests interest rates may not need to climb as high due to tightening bank lending conditions, while former Fed Chair Ben Bernanke emphasizes the current situation is different from 2008. Market expectations for a June rate hike dropped, impacting the iShares U.S. Treasury Bond ETF (GOVT) and the SPDR S&P 500 ETF Trust (SPY).

Portfolio Pulse from Piero Cingari

May 19, 2023 | 4:41 pm

ABBV

The U.S. FDA has approved AbbVie's EPKINLY (epcoritamab-bysp) as the first and only T-cell engaging bispecific antibody for treating adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). EPKINLY is being co-developed by AbbVie and Genmab as part of their oncology collaboration.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 4:37 pm

SPY

House Speaker McCarthy expressed concerns about increased spending next year, stating that he could see the path to a potential issue. This may impact the overall market sentiment.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 4:35 pm